- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0147566

Enomark Pharma Private Limited
About Enomark Pharma Private Limited
Data last updated:
Enomark Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2016PTC282093. Its GSTIN is 08AAPCA5656A1ZN (Rajasthan). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1 Cr. It was formerly known as Aerozest Life Science Private Limited. It is led by directors including Shriram Sawalram Patel (Managing Director) and Umesh Ruparam Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1/A 25 Manali Bldg No. 1 Chs Ltd Evershine Nagar Malad West, Mumbai, Maharashtra, India – 400064.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.56 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹26.85 Lakh (net margin -10.5%) and EBITDA of -₹12.15 Lakh (EBITDA margin -4.7%). Revenue has grown at a compounded annual rate (CAGR) of 388% over three years and 29% over five years.
Its group structure includes 3 subsidiaries.
As per MCA filings, the company has open charges of ₹7.5 Cr on record.
Enomark Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0147566). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Enomark Pharma
Contact details
Enomark Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1/A 25 Manali Bldg No. 1 Chs Ltd Evershine Nagar Malad West, Mumbai, Maharashtra, India – 400064
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Enomark Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Enomark Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Enomark Pharma Private Limited, buy the company report.
Financials of Enomark Pharma Private Limited
FY 2025 filings availableEnomark Pharma Private Limited reported revenue of ₹2.56 Cr (up 172% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 172% growth in the latest year. EBITDA fell 944% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹12.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹26.85 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.7% | ||||
| Net Profit Margin | -10.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Enomark Pharma Private Limited, buy the company report.
Board of directors of Enomark Pharma Private Limited
Enomark Pharma has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shriram Sawalram Patel Also directs: Karkinos Lifescience Private Limited, Chemcopia Ingredients Private Limited, Glenwell Healthcare Private Limited and 2 more | Managing Director | 21 Jan 2022 | 4 Years 10 Months | Current |
| Umesh Ruparam Patel | Director | 21 Jan 2022 | 4 Years 10 Months | Current |
| Jetharam Patel | Director | 14 Jun 2024 | 2 Years 5 Months | Current |
| Laxmanram Ruparam Patel | Director | 30 Sep 2023 | 3 Years 1 Months | Current |
Auditor
Enomark Pharma Private Limited is audited by Abdul Rahim & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Abdul Rahim & Associates | FY 2023 | 140943W |
Shareholding
The shareholding of Enomark Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Enomark Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Mar 2024 | 100907656 | Others | ₹7.5 Cr | Open |
To see the full charge records of Enomark Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Enomark Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Enomark Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 2 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Enomark Healthcare Private Limited |
To see the full MSME payment records of Enomark Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Enomark Pharma has 3 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Karkinos Lifescience Private Limited | U24230MH2023PTC397830 | |
| Glenwell Healthcare Private Limited | U85110RJ2022PTC081640 | |
| Medicopia Pharma Private Limited | U85300RJ2022PTC084397 |
To see the full group structure of Enomark Pharma Private Limited, buy the company report.
GST
Enomark Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAPCA5656A1ZN | Rajasthan | Active | 05 Jul 2022 |
To see the full GST registrations and return filing status of Enomark Pharma Private Limited, buy the company report.
Recent activity
Enomark Pharma Private Limited has 12 board changes on record since 2016: 8 appointments and 4 cessations. The latest: Gopa Ram ceased to be Director on 14 Jun 2024.
5 earlier events are in the company report.
Frequently asked questions
Enomark Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 June 2016 (10+ years old) and is registered under CIN U51909MH2016PTC282093.
Enomark Pharma has 4 current directors:
- Shriram Sawalram Patel - Managing Director
- Umesh Ruparam Patel - Director
- Jetharam Patel - Director
- Laxmanram Ruparam Patel - Director
The latest financial statements of Enomark Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Enomark Pharma is 08AAPCA5656A1ZN, registered in Rajasthan. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Enomark Pharma is U51909MH2016PTC282093. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Enomark Pharma was incorporated on 06 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Gopa Ram ceased to be Director on 14 Jun 2024. Jetharam Patel was appointed as Director on 14 Jun 2024. Laxmanram Ruparam Patel was appointed as Director on 30 Sep 2023. Enomark Pharma has 12 board changes on record in total.
Yes, Enomark Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0147566).
Enomark Pharma has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 2 overdue payments to 2 micro and small suppliers. The latest return was filed on 09 Jun 2019.
The registered office of Enomark Pharma is at 1A 25 Manali Bldg No. 1 Chs Ltd Evershine Nagar Malad West, Mumbai, Maharashtra, India – 400064.
Enomark Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

